Search Results - "Ibba, Maria L."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    Advances in Oligonucleotide Aptamers for NSCLC Targeting by Rotoli, Deborah, Santana-Viera, Laura, Ibba, Maria L, Esposito, Carla L, Catuogno, Silvia

    “…Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer worldwide, with the highest incidence in developed countries. NSCLC patients often…”
    Get full text
    Journal Article
  3. 3

    STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts by Ibba, Maria L., Ciccone, Giuseppe, Rotoli, Deborah, Coppola, Gabriele, Fiorelli, Alfonso, Catuogno, Silvia, Esposito, Carla L.

    Published in Molecular therapy. Nucleic acids (13-06-2023)
    “…The identification of new effective therapeutic options for non-small-cell lung cancer (NSCLC) represents a crucial challenge in oncology. Recent studies…”
    Get full text
    Journal Article
  4. 4

    Advances in mRNA non-viral delivery approaches by Ibba, Maria L., Ciccone, Giuseppe, Esposito, Carla L., Catuogno, Silvia, Giangrande, Paloma H.

    Published in Advanced drug delivery reviews (01-10-2021)
    “…[Display omitted] Messenger RNAs (mRNAs) present a great potential as therapeutics for the treatment and prevention of a wide range of human pathologies,…”
    Get full text
    Journal Article
  5. 5

    Emerging Therapeutic RNAs for the Targeting of Cancer Associated Fibroblasts by Santana-Viera, Laura, Ibba, Maria L, Rotoli, Deborah, Catuogno, Silvia, Esposito, Carla L

    Published in Cancers (26-05-2020)
    “…Tumor mass consists of a complex ensemble of malignant cancer cells and a wide variety of resident and infiltrating cells, secreted factors, and extracellular…”
    Get full text
    Journal Article